Full Press Release Details
SOUTH SAN FRANCISCO, Calif., Sept. 02, 2021 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX), a clinical stage biotechnology company focused on discovering and developing novel therapeutics for the treatment of fibrosis, today announced participation in the following investor conferences:
Citi 16th Annual BioPharma Virtual Conference – Pliant’s senior management team will participate in one-on-one meetings with members of the investment community September 8 - 9, 2021
Cantor 2021 Virtual Global Healthcare Conference – Bernard Coulie, M.D., Ph.D., Pliant’s President and Chief Executive Officer, will present on Wednesday, September 29, 2021, at 2:40 p.m. ET / 11:40 a.m. PT and, along with members of Pliant’s senior management team, will participate in one-on-one meetings with members of the investment community
The webcast replay of the Cantor conference presentation will be archived for 90 days following the conclusion of the event.
About Pliant Therapeutics, Inc.
Investor and Media Contact:
Vice President, Investor Relations and Corporate Communications
Pliant Therapeutics, Inc.